Literature DB >> 15012918

Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure.

R A Anderson1, G R Ellis, Y Y Chirkov, A S Holmes, N Payne, D J Blackman, S K Jackson, M J Lewis, J D Horowitz, M P Frenneaux.   

Abstract

Congestive heart failure (CHF) is associated with oxidative stress. Platelet responsiveness to nitric oxide (NO) donors, are impaired in patients with angina pectoris, possibly by increasing oxidative stress. We investigated the occurrence of platelet resistance to NO in patients, with ischaemic or non-ischaemic cardiomyopathy compared with normal subjects. Anti-aggregatory effects of sodium nitroprusside (SNP), oxidative stress and whole blood superoxide anion content were determined, with correlates of responsiveness to SNP. Inhibition of platelet aggregation by SNP was 65.4+/-3.55% in controls and 59.3+/-4.1% in CHF (P=ns) despite increased oxidative stress and post-aggregation O2- in CHF patients. However, subsets of CHF patients have NO-resistant platelets: this is associated with increasing age and/or increased oxidative stress (both p<0.05).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15012918     DOI: 10.1016/S1388-9842(03)00038-2

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  7 in total

1.  Effects of nitrite infusion on skeletal muscle vascular control during exercise in rats with chronic heart failure.

Authors:  Angela A Glean; Scott K Ferguson; Clark T Holdsworth; Trenton D Colburn; Jennifer L Wright; Alex J Fees; Karen S Hageman; David C Poole; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-14       Impact factor: 4.733

2.  Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite.

Authors:  Abdul R Maher; Sayqa Arif; Melanie Madhani; Khalid Abozguia; Ibrar Ahmed; Bernadette O Fernandez; Martin Feelisch; A G O'Sullivan; Arthur Christopoulos; Aaron L Sverdlov; Doan Ngo; Rustem Dautov; Philip E James; John D Horowitz; Michael P Frenneaux
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 3.  Potential Role of Protein Disulfide Isomerase in Metabolic Syndrome-Derived Platelet Hyperactivity.

Authors:  Renato Simões Gaspar; Andrés Trostchansky; Antonio Marcus de Andrade Paes
Journal:  Oxid Med Cell Longev       Date:  2016-12-07       Impact factor: 6.543

4.  Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.

Authors:  Alessandra Borgognone; Eduard Shantsila; Sophie M Worrall; Eakkapote Prompunt; Thomas Loka; Brodie L Loudon; Myriam Chimen; G Ed Rainger; Janet M Lord; Ashley Turner; Peter Nightingale; Martin Feelisch; Paulus Kirchhof; Gregory Y H Lip; Steve P Watson; Michael P Frenneaux; Melanie Madhani
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

5.  Alterations in platelet bioenergetics in Group 2 PH-HFpEF patients.

Authors:  Quyen L Nguyen; Yinna Wang; Nicole Helbling; Marc A Simon; Sruti Shiva
Journal:  PLoS One       Date:  2019-07-31       Impact factor: 3.240

Review 6.  Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease.

Authors:  Yuliy Y Chirkov; Thanh H Nguyen; John D Horowitz
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923

7.  Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance.

Authors:  Anida Velagic; Jasmin Chendi Li; Cheng Xue Qin; Mandy Li; Minh Deo; Sarah A Marshall; Dovile Anderson; Owen L Woodman; John D Horowitz; Barbara K Kemp-Harper; Rebecca H Ritchie
Journal:  Br J Pharmacol       Date:  2022-04-26       Impact factor: 9.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.